The FDA today issued a draft guidance with recommendations for clinical trials for certain devices intended for treating diabetes.
Included in the guidance are recommendations for feasibility and early feasibility clinical studies for certain medical devices intended to therapeutically improve glycemic control in patients with type 2 diabetes mellitus, independent of medication delivery, according to a news release.
Get the full story at our sister site, Drug Delivery Business News.